Literature DB >> 30455936

Gastroduodenal intussusception due to gastrointestinal stromal tumor.

Utpal De1, Srijan Basu1.   

Abstract

Gastric GIST should be kept in mind in patients with gastric outlet obstruction.

Entities:  

Keywords:  GIST intussusception

Year:  2018        PMID: 30455936      PMCID: PMC6230636          DOI: 10.1002/ccr3.1786

Source DB:  PubMed          Journal:  Clin Case Rep        ISSN: 2050-0904


QUIZ

A 42‐year‐old female presented with symptoms of upper abdominal pain and intermittent vomiting after meals for the past 6 months. She did not have any significant past history. She presented with clinical features of acute gastric outlet obstruction. Blood investigations showed anemia. Endoscopy (Figure 1) revealed a submucosal tumor from the anterior wall of stomach with central ulceration prolapsing into the duodenum. CT scan (Figure 2) demonstrated 8 × 7 × 4 cm sized heterogeneously enhancing pedunculated polypoid mass attached to the antropyloric region, lying within the duodenum extending till its third part. Laparotomy was performed, and the mass was removed with a cuff of anterior wall of stomach with GIA stapler. Postoperative period was uneventful, what is the lesion in the resected specimen of stomach? (Figure 3).
Figure 1

Endoscopy showing submucosal tumor in the antrum with mucosal ulceration (white arrowhead)

Figure 2

CT scan showing gastric tumor invaginating into second part of duodenum (red arrowhead)

Figure 3

Resected specimen of GIST showing apex (red arrow), base (green arrow), and part of cuff of stomach (yellow arrow)

Endoscopy showing submucosal tumor in the antrum with mucosal ulceration (white arrowhead) CT scan showing gastric tumor invaginating into second part of duodenum (red arrowhead) Resected specimen of GIST showing apex (red arrow), base (green arrow), and part of cuff of stomach (yellow arrow)

ANSWER

Gastroduodenal intussusception (10%)1, 2 causing acute gastric outlet obstruction due to pedunculated gastric gastrointestinal stromal tumor (GIST) is rare. GIST (mesenchymal tumor) is pathologically defined by positive immunostaining for c‐kit proto‐oncogene—CD117 (95%) and CD34 (60%‐70%).2 Ulceration of the apical mucosa results in bleeding (50%).2 Endoscopy and CT scan are diagnostic. Treatment for localized GIST is complete surgical resection. Fletcher's risk stratification indices include tumor size, mitotic index, nonradical resection (R1), and tumor rupture.1, 2 Postoperative chemotherapy improves relapse‐free survival, but overall survival remains unchanged.

CONFLICT OF INTEREST

None declared.

AUTHOR CONTRIBUTION

UD and SB: conceived of the presented idea. UD: encouraged SB to investigate and supervised the findings of this work. All authors: discussed the results and contributed to the final manuscript.
  2 in total

Review 1.  Recent advances in the treatment of gastrointestinal stromal tumors.

Authors:  César Serrano; Suzanne George
Journal:  Ther Adv Med Oncol       Date:  2014-05       Impact factor: 8.168

Review 2.  Gastrointestinal stromal tumor: recent advances in pathology and genetics.

Authors:  Hidetaka Yamamoto; Yoshinao Oda
Journal:  Pathol Int       Date:  2014-11-20       Impact factor: 2.534

  2 in total
  3 in total

Review 1.  Gastroduodenal intussusception caused by gastric gastrointestinal stromal tumor in adults: a case report and literature review.

Authors:  Wenbing Zhang; Haifeng Chen; Lulu Zhu; Zhiyuan Kong; Tingting Wang; Weiping Li
Journal:  J Int Med Res       Date:  2022-05       Impact factor: 1.573

2.  Gastroduodenal intussusception caused by gastric gastrointestinal stromal tumor: A case report and review of the literature.

Authors:  Yi-Lun Hsieh; Wen-Hung Hsu; Ching-Chun Lee; Chun-Chieh Wu; Deng-Chyang Wu; Jeng-Yih Wu
Journal:  World J Clin Cases       Date:  2021-02-06       Impact factor: 1.337

Review 3.  Case report and literature review: patient with gastroduodenal intussusception due to the gastrointestinal stromal tumor of the lesser curvature of the gastric body.

Authors:  Mihajlo Đokić; Jerica Novak; Miha Petrič; Branislava Ranković; Miha Štabuc; Blaž Trotovšek
Journal:  BMC Surg       Date:  2019-10-29       Impact factor: 2.102

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.